Back
4D Molecular Therapeutics Quote, Financials, Valuation and Earnings
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Sell
26
FDMT
4D Molecular Therapeutics
Last Price:
7.89
Seasonality Move:
57.95%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.4D Molecular Therapeutics Price Quote
$7.89
+0.19 (+2.47%)
(Updated: November 14, 2024 at 12:15 PM ET)
4D Molecular Therapeutics Key Stats
Sell
26
4D Molecular Therapeutics (FDMT)
is a Sell
Day range:
$7.68 - $8.02
52-week range:
$7.72 - $36.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
18.46
P/B ratio:
0.7%
Volume:
534.3K
Avg. volume:
720.7K
1-year change:
-26.88%
Market cap:
$409M
Revenue:
$20.7M
EPS:
$-2.3
How Much Does 4D Molecular Therapeutics Make?
-
How Much Are 4D Molecular Therapeutics's Sales Annually?
FDMT Revenues are $20.7M -
How Much Profit Does 4D Molecular Therapeutics's Make A Year?
FDMT net income is -$100.8M
Is 4D Molecular Therapeutics Growing As A Company?
-
What Is 4D Molecular Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.98% -
What Is 4D Molecular Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
4D Molecular Therapeutics Stock Price Performance
-
Did 4D Molecular Therapeutics Stock Go Up Last Month?
4D Molecular Therapeutics share price went down by -16.03% last month -
Did FDMT's Share Price Rise Over The Last Year?
FDMT share price fell by -26.88% over the past 1 year
What Is 4D Molecular Therapeutics 52-Week High & Low?
-
What Is 4D Molecular Therapeutics’s 52-Week High Share Price?
4D Molecular Therapeutics has traded as high as $36.25 over the past 52 weeks -
What Is 4D Molecular Therapeutics’s 52-Week Low Share Price?
4D Molecular Therapeutics has traded as low as $7.72 over the past 52 weeks
4D Molecular Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy 4D Molecular Therapeutics?
-
How Much Debt Does 4D Molecular Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does 4D Molecular Therapeutics Have?
Cash and short term investments quarterly total is $541.9M -
What Is 4D Molecular Therapeutics’s Book Value Per Share?
Book value per share is 11.33
Is 4D Molecular Therapeutics Cash Flow Positive?
-
What Is FDMT Cash Flow From Operations?
Cash flow from operations (TTM) is -$85.2M -
What Is 4D Molecular Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $351.4M -
What Is 4D Molecular Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$313.5M
4D Molecular Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
FDMT return on invested capital is -25.54% -
What Is 4D Molecular Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -23.85% -
What Is FDMT Return On Equity?
ROE is a measure of profitability and is -25.54%
4D Molecular Therapeutics Earnings Date & Stock Price
-
What Is 4D Molecular Therapeutics's Stock Price Today?
A single share of FDMT can be purchased today for 7.70 -
What Is 4D Molecular Therapeutics’s Stock Symbol?
4D Molecular Therapeutics trades on the nasdaq under the ticker symbol: FDMT -
When Is 4D Molecular Therapeutics’s Next Earnings Date?
The next quarterly earnings date for 4D Molecular Therapeutics is scheduled on November 15, 2024 -
When Is FDMT's next ex-dividend date?
4D Molecular Therapeutics's next ex-dividend date is November 14, 2024 -
How To Buy 4D Molecular Therapeutics Stock?
You can buy 4D Molecular Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
4D Molecular Therapeutics Competitors
-
Who Are 4D Molecular Therapeutics's Competitors?
Below is a list of companies who compete with 4D Molecular Therapeutics or are related in some way:
4D Molecular Therapeutics Dividend Yield
-
What Is FDMT Dividend Yield?
4D Molecular Therapeutics’s dividend yield currently is 0% -
What Is 4D Molecular Therapeutics’s Payout Ratio?
4D Molecular Therapeutics’s payout ratio is 0% -
When Did 4D Molecular Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 14, 2024 -
What Is 4D Molecular Therapeutics’s Dividend Per Share?
4D Molecular Therapeutics pays a dividend of $0.00 per share
4D Molecular Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 10.99% |
| Revenue: | -97.91% | -99.27% |
Analyst Recommendations
| Buy Recommendations: | 5 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 50.00 |
| Upside from Last Price: | 549.35% |